3-Chloro-4-fluorobenzotrifluoride

We are 3-Chloro-4-fluorobenzotrifluoride CAS:78068-85-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:   3-Chloro-4-fluorobenzotrifluoride
CAS.NO:78068-85-6
Synonyms: 3-chloro-4-fluorobezotrilfuoride;
3-CHOLOR-4-FLUOROBENZO-TRIFLUORIDE;
2-Clor-1-fluor-4-(trifluormethyl)bezol;
3-chloro-4-chlorobenzotrifluoride;
3-chloro-4-fluorobenzontrifluoride;
Molecular Formula: C7H3ClF4
Molecular Weight:198.54500
 
Physical and Chemical Properties:
Density:1.49g/cm3
Melting point:/
Boiling point:136.8ºC at 760 mmHg
Flash point:42.2ºC
Index of Refraction:1.4355
 
Specification:
Appearance:Colorless Transparent Liquid
Purity:≥98.0%
 
Packing: according to customer request
Storage:Keep away from heat, sparks, and flame. Keep away from sources of ignition. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Flammables-area.
Application:  Applicationd For intermediates

3-Chloro-4-fluorobenzotrifluoride


Related News: Fate Therapeutics, Inc. recently announced new in vivo preclinical data for FT819, its first off-the-shelf, iPSC-derived chimeric antigen receptor (CAR) T-cell product candidate, at the 61st American Society of Hematology (ASH) Meeting and Exposition in Orlando, FL.2-Chloro-3-fluoro-5-nitropyridine Fate Therapeutics, Inc. recently announced new in vivo preclinical data for FT819, its first off-the-shelf, iPSC-derived chimeric antigen receptor (CAR) T-cell product candidate, at the 61st American Society of Hematology (ASH) Meeting and Exposition in Orlando, FL.2- (4-bromo-fenil) -1 (9) H-benzo [d] imidazo [1,2-a] imidazol CAS:30513-47-4 At present, there are more than 8,000 domestic API manufacturers, but they mainly produce bulk APIs with low technical content.Bromoform CAS:75-25-2 Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added “The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added “The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.

Related Products
Product Name
L-alanyl-L-alanine View Details
5-Amino-2-chloro-6-methylpyridine View Details
4,4,4-Trifluoro-1-(4-methylphenyl)butane-1,3-dione View Details
Acetyl Hexapeptide-30 manufacturer 3-Cyclopropylmethoxy-4-difluoromethoxybenzoic Acid manufacturer dec-9-enoic acid manufacturer 4-Aminobenzotrifluoride manufacturer ethyl 3-cyclopropyl-3-oxopropanoate manufacturer